How many insider declarations has AH Equity Partners Bio II, L.L.C. filed?

AH Equity Partners Bio II, L.L.C. has filed 3 public insider declarations with SEC (Form 4).

What is AH Equity Partners Bio II, L.L.C.'s role?

AH Equity Partners Bio II, L.L.C.'s reported role is not specified by the regulator across the filings.

Which companies does AH Equity Partners Bio II, L.L.C. report trades for?

AH Equity Partners Bio II, L.L.C. reports trades for 2 companies, including EQRx, Inc..

What is AH Equity Partners Bio II, L.L.C.'s declared buy vs sell volume?

Across the available history, declared buys total 0 and disposals 10.1M€.

← Executives ★ Sign in to follow

AE

AH Equity Partners Bio II, L.L.C.

·SEC (Form 4)

EQRx, Inc.Nautilus Biotechnology, Inc.

0

申报总数

0

公司

—

▲ 买入（0 笔）

€1012万

▼ 卖出（2 笔）

内部人交易记录

其他

已披露买入

0

已披露卖出

2

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

Discover the detailed record of transactions filed by AH Equity Partners Bio II, L.L.C.. Director active across 2 companies, notably EQRx, Inc.. In total, 3 reports have been recorded. Split: 0 buy · 2 sells. Total volume traded: €10.1m. History available since 2 June 2026. The latest transaction was disclosed on 2 June 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.

Companies and markets linked to AH Equity Partners Bio II, L.L.C.

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

EQRx, Inc. (US)Nautilus Biotechnology, Inc. (US)

申报3 总计

▼

AH Equity Partners Bio II, L.L.C.

10% Owner高管2026年6月2日Nautilus Biotechnology, Inc.

US$1085万28SEC ↗

4,615,974 股@ US$2.3510.07% mcap92.3% 占其流量Common StockSEC:0001231919-26-000599:0

▼

AH Equity Partners Bio II, L.L.C.

10% Owner高管2026年6月2日Nautilus Biotechnology, Inc.

US$902,46115SEC ↗

384,026 股@ US$2.350.84% mcap7.7% 占其流量Common StockSEC:0001231919-26-000599:1

●

AH Equity Partners Bio II, L.L.C.

高管2023年11月9日EQRx, Inc.

0SEC ↗

12,264 股Common StockSEC:0000899243-23-020289:0

3 条申报中的 3 条

InsidersTradesSigma

← Executives ★ Sign in to follow

AE

AH Equity Partners Bio II, L.L.C.

·SEC (Form 4)

EQRx, Inc.Nautilus Biotechnology, Inc.

0

申报总数

0

公司

—

▲ 买入（0 笔）

€1012万

▼ 卖出（2 笔）

内部人交易记录

其他

已披露买入

0

已披露卖出

2

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

Discover the detailed record of transactions filed by AH Equity Partners Bio II, L.L.C.. Director active across 2 companies, notably EQRx, Inc.. In total, 3 reports have been recorded. Split: 0 buy · 2 sells. Total volume traded: €10.1m. History available since 2 June 2026. The latest transaction was disclosed on 2 June 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.